FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Generics | EMEA | Regulators | New Drugs | Novacea | Millipore

ALSO NOTED: EU panel recommends Bayer, GSK drugs; Novacea names new CEO; and much more...

Tools

> An EMEA advisory panel has issued six positive opinions on marketing applications for new drugs, paving the way for EU marketing approval. Report

> Chutes & Ladders: Novacea has elected John P. Walker as CEO. He will continue to serve the Chairman of the company. Release

> Dr. Anthony S. Fauci, the director of the National Institute of Allergy and Infectious Diseases has won the Lasker Prize. Report

> Millipore is expanding on its reputation as a filtration supplier to scientific labs around the globe. Report

> Generics may be the bane of Big Pharma, but they're inflation-fighting ninjas. Over the last 12 months, prescription drug prices edged up by a measly 1 percent--the lowest rate of inflation in three decades. Report

> Pfizer is looking to set up its Japanese R&D operation, previously slated for shutdown, as an independent company--with the help of a few investors, of course. Report

And Finally... An ancient mechanism for coping with stresses also gives cancer a boost. Release


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Generics   EMEA   Regulators   New Drugs   Novacea   Millipore   John P. Walker